Kratz Johannes R, Woodard Gavitt, Jablons David M
Department of Thoracic Surgery, University of California, San Francisco, Box 0118, San Francisco, CA 94143-0118, USA.
Department of Surgery, University of California, San Francisco, Box 0470, 513 Parnassus Avenue, 321, San Francisco, CA 94122, USA.
Thorac Surg Clin. 2017 May;27(2):149-157. doi: 10.1016/j.thorsurg.2017.01.008.
Superior sulcus tumors have posed a formidable therapeutic challenge since their original description by Pancoast and Tobias in the early twentieth century. Initial therapeutic efforts with radiotherapy were associated with high rates of relapse and mortality. Bimodality therapy with complete surgical resection in the 1960s paved the way for trimodality therapy as the current standard of care in the treatment of superior sulcus tumors. The evolution of treatment approaches over time has provided outcomes that come increasingly closer to rivaling those of similarly staged nonapical lung cancer.
自20世纪初潘科斯特和托拜厄斯首次描述上叶沟肿瘤以来,它们一直构成了一项艰巨的治疗挑战。最初采用放射治疗的治疗效果伴随着高复发率和死亡率。20世纪60年代采用完全手术切除的双峰治疗为三联治疗铺平了道路,成为目前治疗上叶沟肿瘤的标准治疗方法。随着时间的推移,治疗方法的演变所带来的结果越来越接近与分期相似的非肺尖部肺癌的治疗结果相媲美。